Not finding it? Sign in to also search OpenAlex live.
-
Transcranial Magnetic Stimulation as a Translational Biomarker in Early‐Phase Anti‐Seizure Medication Development: A Randomized, Double‐Blind, Placebo‐Controlled Study in Generalized Epilepsy2026 Clinical Pharmacology & Therapeutics article Neuroscience Transcranial Magnetic Stimulation Studies Open access
Catherine M.K.E. de Cuba, Titia Q. Ruijs, Annika A. de Goede, Robert Jan Doll, Maria Joanna Juachon, Michel J. A. M. van Putten, +2 more
1citations -
Impact of Minimal Residual Disease on Progression-Free Survival in Patients with Newly Diagnosed Multiple Myeloma Treated with Isatuximab, Lenalidomide, Bortezomib and Dexamethasone Induction Therapy in the Phase 3 GMMG-HD7 Trial
Hans Jürgen Salwender, Michael Hundemer, Uta Bertsch, Ema Požek, Axel Benner, Roland R. Fenk, +27 more
1citations -
First Experiences in Performance Benchmarking with the New SPEChpc 2021 Suites - Measurement Data2021 Zenodo (CERN European Organization for Nuclear Research) dataset Computer Science Parallel Computing and Optimization Techniques Open access
Holger Brunst, Sunita Chandrasekaran, Florina M. Ciorba, Nick Hagerty, Robert Henschel, Guido Juckeland, +3 more
1citations -
Porous organic frameworks for preferable adsorption of trans-1,2-diols over cis-1,2-diols2022 Applied Materials Today article Materials Science Covalent Organic Framework Applications Open access
Tobias Zensen, Theresa Röper, Thomas Fuchs, Nina M. Sackers, Stephanie Bachmann, Ann‐Christin Pöppler, +3 more
1citations -
P1048: MYF3001: A RANDOMIZED OPEN LABEL, PHASE 3 STUDY TO EVALUATE IMETELSTAT VERSUS BEST AVAILABLE THERAPY IN PATIENTS WITH INTERMEDIATE-2 OR HIGH-RISK MYELOFIBROSIS REFRACTORY TO JANUS KINASE INHIBITOR
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +11 more
1citations -
A Randomized Open-Label, Phase 3 Study to Evaluate Imetelstat Versus Best Available Therapy (BAT) in Patients with Intermediate-2 (Int-2) or High-Risk Myelofibrosis (MF) Refractory to Janus Kinase Inhibitor (JAKi)
John O Mascarenhas, Claire N. Harrison, Jean‐Jacques Kiladjian, Rami S. Komrokji, Steffen Koschmieder, Alessandro Maria Vannucchi, +9 more
1citations -
The 2025 Accra Declaration on Upskilling and Cost- Effective Cardiac Surgery in Africa2026 European Journal of Cardio-Thoracic Surgery article Medicine Global Health and Surgery Open access
Charles Yankah, Jonathan O. Nwiloh, Carlos A Mestres, Abdelmalek Bouzid, Tom Philip Mwambu, Mohamed Debièche, +17 more
1citations -
Screening for cognitive impairment in routine clinical oncology practice: a pilot study using patient-reported outcome measures and online cognitive testing in melanoma and breast cancer patients2025 Supportive Care in Cancer article Medicine Cancer-related cognitive impairment studies Open access
Elaine A. C. Albers, Kelly M. de Ligt, Iris M. C. van der Ploeg, Michel W.J.M. Wouters, Sanne B. Schagen, Lonneke Veronique van de Poll-Franse
1citations -
Self-consistent integrated modeling of combined hybrid discharge-laser produced plasma devices for extreme ultraviolet metrology2023 Physics of Plasmas article Physics and Astronomy Laser-Plasma Interactions and Diagnostics Open access
Valeryi A. Sizyuk, A. Hassanein, Florian Melsheimer, Larissa Juschkin, Tatyana Sizyuk
1citations